Characterization of neutralizing antibodies to Far Eastern of tick-borne encephalitis virus subtype and the antibody avidity for four tick-borne encephalitis vaccines in human

Vaccine

Volumn 27, Issue 21, 2009, Pages 2899-2904

  Leonova, Galina N ^a   Pavlenko, Elena V ^a  

^a Institute of Epidemiology and Microbiology   (Russian Federation)

Author keywords

TBE vaccines; Total and avidity antibodies

Indexed keywords

ENCEVIR; IMMUNOGLOBULIN G ANTIBODY; NEUTRALIZING ANTIBODY; TICK BORNE ENCEPHALITIS VACCINE; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANTIBODY TITER; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; HUMAN EXPERIMENT; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; MALE; NONHUMAN; PRIORITY JOURNAL; SEROCONVERSION; SERODIAGNOSIS; TICK BORNE ENCEPHALITIS; TICK BORNE ENCEPHALITIS FLAVIVIRUS; VIRUS STRAIN;

ANTIBODIES, VIRAL; ANTIBODY AFFINITY; ENCEPHALITIS VIRUSES, TICK-BORNE; ENCEPHALITIS, TICK-BORNE; FAR EAST; HUMANS; IMMUNOASSAY; NEUTRALIZATION TESTS; TITRIMETRY; VIRAL VACCINES;

EID: 64649088751     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.02.069     Document Type: Article

References (23)

1. Charrel R.N., Attoui H., Butenko A.M., Clegg J.C., Deubel V., Frolova T.V., et al. Tick-borne virus diseases of human interest in Europe. Clin Microbiol Infect 10 12 (2004) 1040-1055
2. Ecker M., Allison S.L., Meixner T., and Heinz F.X. Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia. J Gen Virol 80 (1999) 179-185
3. Loktev V.B. Tick-borne encephalitis virus, the genetic characteristic and variability in modern world. Byull SO RAMSci 4 (2007) 14-21 [Russian]
4. Zlobin V.I., Belikov S.I., Dzhioev Yu.P., Demina T.V., and Kozlova I.V. Molecular Epidemiology of tick-borne encephalitis. Irkutsk: RIO VSNTs SO RAMSci (2003) 272 [Russian]
5. Heinz F.X., and Kunz C. Tick-borne encephalitis and the impact of vaccination. Arch Virol 18 (2004) 201-205
6. Leonova G.N., Pavlenko E.V., and Krylova N.V. Vaccine Prevention of Tick-Borne Encephalitis (2006), Vladivostok p. 100 [Russian]
7. Kunz C. TBE vaccination and Austrian experience. Vaccine 2003;21:S1/50-55.
8. Romanenko V.V., Esyunina M.S., and Kilyachina A.S. An experience in realizing programs of mass population immunization against tick-borne encephalitis in Sverdlovsk oblast. Vopr Virusol 6 (2007) 22-25 [Russian]
9. Vorobyova M.S., Rasshchepkina M.N., and Ladyzhenskaya I.P. Vaccine, immunoglobulin, and test kits for prevention and diagnostics of tick-borne encephalitis. Vopr Virusol 6 (2007) 30-36 [Russian]
10. Holzmann H., Vorobyova M.S., Ladyzhenskaya I.P., Ferenczi E., Kundi M., Kunz C., et al. Molecular epidemiology of tick-borne-encephalitis virus: cross-protection between European and Far Eastern subtypes. Vaccine 10 (1992) 345-349
11. Takashima I., Hayasaka D., Goto A., Kariwa H., and Mizutani T. Epidemiology of tick-borne encephalitis (TBE) and phylogenetic analysis of TBE viruses in Japan and Far Eastern Russia. J Infect Dis 54 (2001) 1-11
12. Ternovoi V.A., Protopopova E.V., Chausov E.V., Novikov D.V., Leonova G.N., Netesov S.V., et al. Novel variant of tick-borne encephalitis virus, Russia. Emerg Infect Dis 13 10 (2007) 1574-1578
13. Loktev V.B., Ternovoi V.A., and Netesov S.V. Molecular genetic characterization of tick-borne encephalitis virus. Vopr Virusol 5 (2007) 10-16 [Russian]
14. Pogodina V.V., Karan' L.S., Kolyasnikova N.M., Levina L.S., Malenko G.V., Gamova E.G., et al. The evolution of tick-borne encephalitis and the problem of the pathogen evolution. Vopr Virusol 5 (2007) 16-26 [Russian]
15. Pavlenko E.V., Leonova G.N., and Maistrovskaya O.S. Comparative studying immunogenicity of vaccines against tick-borne encephalitis. Far Eastern J Infect Pathol 11 (2007) 57-62 [Russian]
16. Raspopin V.V., Rasumov I.A., Kasachinskaya Ye.I., Protopopova Ye.V., Loktev V.B., Topychcanova N.G., et al. The avidity index of specific IgG in the diagnosis of diseases caused by West Nile and tick-borne encephalitis viruses. Clin Lab Diagn 7 (2007) 29-32 [Russian]
17. Leonova G.N., Ternovoi V.A., Pavlenko E.V., Maistrovskaya O.S., Protopopova E.V., and Loktev V.B. Evaluation of vaccine Encepur® Adult for induction of human neutralizing antibodies against recent Far Eastern subtype strains of tick-borne encephalitis. Vaccine 25 (2007) 895-901
18. Heinz F.X., Holzmann H., Essl A., and Kundt M. Analysis of the efficiency of tick-borne encephalitis vaccination in the population in the natural foci of Austria. Vopr Virusol 53 2 (2008) 19-27 [Russian]
19. Simmons V., Porter K.R., Hayes C.G., Vaughn D.M., and Putnak R. Characterization of antibody responses to combinations of a Dengue virus type 2 DNA vaccine and two Dengue virus type 2 protein vaccines in rhesus macaques. J Virol 10 (2006) 9577-9585
20. Fox J.L., Stuart H.L., Tobler L.H., and Busch M.P. Immunoglobulin G avidity in differentiation between early and late antibody responses to West Nile virus. Clin Vaccine Immunol 1 (2006) 33-36
21. Inouye S., Hasegawa A., Matsuno S., and Katow S. Changes in antibody avidity after virus infections: detection by an immunosorbent assay in which a mild protein-denaturing agent is employed. J Clin Microbiol 9 (1984) 525-529
22. Suligoi B., Galli C., Massi M., Di Sora F., Sciandra M., Pezzotti P., et al. Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method. J Clin Microbiol 11 (2002) 4015-4020
23. Mubareka S., Richards H., Gray M., and Tipples G.A. Evaluation of commercial rubella immunoglobulin G avidity assays. J Clin Microbiol 1 (2007) 231-233